IRIS
PEVIANI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 712
EU - Europa 509
AS - Asia 260
Totale 1.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 706
CN - Cina 247
IE - Irlanda 189
IT - Italia 96
FI - Finlandia 63
UA - Ucraina 61
DE - Germania 40
SE - Svezia 23
BE - Belgio 17
GB - Regno Unito 13
CA - Canada 6
FR - Francia 5
IN - India 5
MY - Malesia 2
VN - Vietnam 2
GR - Grecia 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
SG - Singapore 1
Totale 1.481
Salva come PNG Salva come JPEG
Città #
Dublin 189
Chandler 175
Jacksonville 80
Nanjing 77
Ann Arbor 54
Pavia 49
Ashburn 46
Beijing 38
Princeton 35
Lawrence 34
Wilmington 31
Nanchang 29
Helsinki 27
Medford 23
Hebei 18
New York 18
Jiaxing 15
Changsha 14
Brussels 13
Shanghai 13
Boardman 12
Shenyang 12
Tianjin 12
Woodbridge 9
Seattle 8
Falls Church 6
Los Angeles 6
Milan 6
Washington 6
Hangzhou 5
Toronto 5
Des Moines 4
Piemonte 4
Pune 4
Tappahannock 4
Fairfield 3
Auburn Hills 2
Calusco d'Adda 2
Casorate Primo 2
Dong Ket 2
Jinan 2
Ningbo 2
Norwalk 2
Rockville 2
Torino 2
Turin 2
Amsterdam 1
Augsburg 1
Borås 1
Gallarate 1
Houston 1
Jinhua 1
Kunming 1
Lanzhou 1
Qingdao 1
Redwood City 1
Shaoxing 1
Suizenji 1
Verona 1
West Palm Beach 1
Zhengzhou 1
Totale 1.119
Salva come PNG Salva come JPEG
Nome #
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 85
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 77
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 71
In Situ Agar – Carbomer Hydrogel Polycondensation:a Chemical Approach to Regenerative Medicine 70
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 68
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 67
Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase. 67
Identification of a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. 63
Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. 60
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 53
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 49
Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. 49
Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice. 48
Use of arylalkanolamines as sigma-1 receptor antagonists 48
Studies on the enantiomers of RC-33, promising neuroprotective agents acting as sigma1 receptor agonists. Isolation, configurational assignment and biological profile 47
COMPOSITIONS AND METHODS FOR TARGETING CELLS 47
Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis 44
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 43
Sigma1 Receptor Agonists in motor dysfunction pathologies treatment – a medicinal chemistry perspective 39
Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: A challenge or an opportunity? 38
Neurophysiological characterisation of the g93a ALS rat model 36
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 35
COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM 35
Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading 34
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells 29
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 28
Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. 27
Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma 27
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System 26
Synthesis and characterization of a “clickable” pbr28 tspo-selective ligand derivative suitable for the functionalization of biodegradable polymer nanoparticles 25
T1-weighted dynamic contrast-enhanced MRI is a noninvasive marker of epidermal growth factor receptor VIII status in cancer stem cell-derived experimental glioblastomas 19
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release 19
Metallothioneins are neuroprotective agents in lysosomal storage disorders 15
Simultaneous flow cytometric characterization of multiple cell types retrieved from mouse brain/spinal cord through different homogenization methods 12
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 10
null 9
Fast deep learning reconstruction techniques for preclinical magnetic resonance fingerprinting 6
Totale 1.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 3 2 2
2019/2020310 84 108 1 14 3 12 2 15 5 20 31 15
2020/2021164 14 12 4 14 3 18 1 41 17 18 16 6
2021/2022173 7 2 8 3 5 7 7 15 16 6 18 79
2022/2023529 56 54 1 33 43 58 0 29 231 2 12 10
2023/2024188 27 30 7 10 22 59 5 18 2 8 0 0
Totale 1.525